Status:
COMPLETED
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
Lead Sponsor:
Stanford University
Conditions:
Leukemia, Myelocytic, Acute
Leukemia
Eligibility:
All Genders
16-69 years
Phase:
PHASE2
Brief Summary
Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.
Detailed Description
To use high dose chemotherapy with autologous stem cell rescue to try to increase the chance of long term control and cure of the disease.
Eligibility Criteria
Inclusion
- must be in remission
- adequate organ function
Exclusion
- prior MDS
- active infection
- liver disease
Key Trial Info
Start Date :
November 1 1995
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00186381
Start Date
November 1 1995
End Date
March 1 2007
Last Update
July 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305